Forte Biosciences (FBRX)

• Market cap: $618M
• 1 day: 7.02%
• 5 days: 12.62%
• 1 month: 14.11%
• 3 months: -5.84%
• 6 months: 176.54%
• Year to date: 27.78%
• 1 year: 353%
• 5 years: -96.52%
• 10 years: -99.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Employees: 19